Open Access. Powered by Scholars. Published by Universities.®

Pharmacy and Pharmaceutical Sciences Commons

Open Access. Powered by Scholars. Published by Universities.®

4,717 Full-Text Articles 9,707 Authors 950,796 Downloads 188 Institutions

All Articles in Pharmacy and Pharmaceutical Sciences

Faceted Search

4,717 full-text articles. Page 186 of 190.

De Novo Sequencing And Analysis Of The American Ginseng Root Transcriptome Using A Gs Flx Titanium Platform To Discover Putative Genes Involved In Ginsenoside Biosynthesis, Chao Sun, Ying Li, Qiong Wu, Hongmei Luo, Yongzhen Sun, Jingyuan Song, Ed Lui, Shilin Chen 2010 The University of Western Ontario

De Novo Sequencing And Analysis Of The American Ginseng Root Transcriptome Using A Gs Flx Titanium Platform To Discover Putative Genes Involved In Ginsenoside Biosynthesis, Chao Sun, Ying Li, Qiong Wu, Hongmei Luo, Yongzhen Sun, Jingyuan Song, Ed Lui, Shilin Chen

Edmund M. K. Lui

BACKGROUND: American ginseng (Panax quinquefolius L.) is one of the most widely used herbal remedies in the world. Its major bioactive constituents are the triterpene saponins known as ginsenosides. However, little is known about ginsenoside biosynthesis in American ginseng, especially the late steps of the pathway. RESULTS: In this study, a one-quarter 454 sequencing run produced 209,747 high-quality reads with an average sequence length of 427 bases. De novo assembly generated 31,088 unique sequences containing 16,592 contigs and 14,496 singletons. About 93.1% of the high-quality reads were assembled into contigs with an average 8-fold coverage ...


Identification Of 2-Aminothiazole-4-Carboxylate Derivatives Active Against Mycobacterium Tuberculosis H37rv And The B-Ketoacyl-Acp Synthase Mtfabh, Philadelphia University 2010 Philadelphia University

Identification Of 2-Aminothiazole-4-Carboxylate Derivatives Active Against Mycobacterium Tuberculosis H37rv And The B-Ketoacyl-Acp Synthase Mtfabh, Philadelphia University

Philadelphia University, Jordan

No abstract provided.


Learning Bridge: Curricular Integration Of Didactic And Experiential Education, Reza Karimi, Cassandra S. Arendt, Pauline Cawley, Amber V. Buhler, Fawzy Elbarbry, Sigrid C. Roberts 2010 Pacific University

Learning Bridge: Curricular Integration Of Didactic And Experiential Education, Reza Karimi, Cassandra S. Arendt, Pauline Cawley, Amber V. Buhler, Fawzy Elbarbry, Sigrid C. Roberts

Faculty Scholarship (PHRM)

Objectives. To assess the impact of a program to integrate introductory pharmacy practice experiences with pharmaceutical science topics by promoting active learning, self-directed learning skills, and critical-thinking skills.
Design. The Learning Bridge, a curriculum program, was created to better integrate the material first-year (P1) students learned in pharmaceutical science courses into their introductory pharmacy practice experiences. Four Learning Bridge assignments required students to interact with their preceptors and answer questions relating to the pharmaceutical science material concurrently covered in their didactic courses.
Assessment. Surveys of students and preceptors were conducted to measure the effectiveness of the Learning Bridge process. Feedback ...


Methods And Compositions For Optimizing Blood And Tissue Stability Of Camptothecin And Other Albumin-Binding Therapeutic Compounds, Thomas G. Burke, Daniel C. Carter 2010 University of Kentucky

Methods And Compositions For Optimizing Blood And Tissue Stability Of Camptothecin And Other Albumin-Binding Therapeutic Compounds, Thomas G. Burke, Daniel C. Carter

Pharmaceutical Sciences Faculty Patents

The present invention provides methods and formulations for optimizing the anti-cancer and anti-HIV activities of a camptothecin drug, including camptothecin and its related analogs including 9-aminocamptothecin and 9-nitrocamptothecin. The invention involves methodologies and formulations that limit human serum albumin-mediated reduction of the anti-cancer and anti-HIV effects of the camptothecins, and the methods and formulations provide combination therapies in which binding of the camptothecin agent to human serum albumin can be modulated by the administration of a competing agent that also binds human serum albumin. Reduced camptothecin drug binding to human serum albumin can result in elevated camptothecin free drug levels ...


Sequence And Biochemical Characterization Of Equilibrative Nucleoside Transporters From Crithidia Fasciculata: Seeking Ligand Binding Residues, Cassandra S. Arendt, Stephen Beverley, Buddy Ullman 2010 Pacific University

Sequence And Biochemical Characterization Of Equilibrative Nucleoside Transporters From Crithidia Fasciculata: Seeking Ligand Binding Residues, Cassandra S. Arendt, Stephen Beverley, Buddy Ullman

Faculty Scholarship (PHRM)

Eukaryotic cells acquire purines via de novo synthesis or salvage mechanisms. Unlike human cells, protozoan parasites from the Apicomplexan and Trypanosomatid lineages such as Plasmodium, Toxoplasma, Leishmania, Trypanosoma and Crithidia species lack de novo purine synthesis enzymes, and therefore rely on salvage of pre-formed purine bases for growth and proliferation, making purine salvage an attractive drug target. A key step in purine salvage is transport of purine nucleobases and nucleosides into the cell, and each species encodes a unique repertoire of transporter proteins from the equilibrative nucleoside transporter (ENT) family, each with its own ligand preference. No detailed structural information ...


The Meta Isomer Of Acetaminophen Is A Time Dependent Inhibitor Of Human Cyp2e1, John Harrelson, Sidney D. Nelson 2010 Pacific University

The Meta Isomer Of Acetaminophen Is A Time Dependent Inhibitor Of Human Cyp2e1, John Harrelson, Sidney D. Nelson

Faculty Scholarship (PHRM)

N-acetyl-m-aminophenol (3’-hydroxyacetanilide, AMAP) is the meta isomer of acetaminophen (4’-hydroxyacetanilide, APAP), the widely used analgesic that is safe at therapeutic doses but is hepatotoxic at larger doses. Unlike APAP, AMAP does not cause hepatotoxicity in mice even though AMAP and its metabolites covalently bind to hepatic proteins at levels comparable to APAP. Therefore, comparative studies with APAP and AMAP have been used in order to investigate mechanisms of toxicity and structure-toxicity relationships. However, the relationship between AMAP and CYP2E1, the enzyme generally implicated in the amplification of APAP-induced hepatotoxicity after ethanol ingestion, has not been ...


Patient Centered Care Approach To Adherence With Cardiovascular Medications: Self-Determination Theory Integration, David S. Li 2010 Old Dominion University

Patient Centered Care Approach To Adherence With Cardiovascular Medications: Self-Determination Theory Integration, David S. Li

Health Services Research Dissertations

Problem statement. Behavioral intervention is used to improve adherence with medication in patients with cardiovascular diseases (CVD), but the effect was not sustainable. Patient-centered care (PCC) as a consumer movement has gained acceptance, but it lacks a theoretical framework. Self-determination theory (SDT) may provide an alternative to improve patients' adherence to chronic cardiovascular medication, as well as a theoretical framework for PCC. Both approaches to CVD management have not been evaluated.

Methods. The study was a quasi-experimental pretest posttest comparison design with consecutive sampling of a hospitalized cardiac patient population. Sixty patients each for the usual care (UC) group and ...


More Than A Prescription, Marc A. Sweeney 2010 Cedarville University

More Than A Prescription, Marc A. Sweeney

Pharmacy Practice Faculty Publications

No abstract provided.


Resolution Of Clinical Signs Of Ventilator-Associated Pneumonia In Trauma Patients, Kathryn A. Connor, Joseph M. Swanson, Bradley A. Boucher, G. Christopher Wood 2010 St. John Fisher College

Resolution Of Clinical Signs Of Ventilator-Associated Pneumonia In Trauma Patients, Kathryn A. Connor, Joseph M. Swanson, Bradley A. Boucher, G. Christopher Wood

Pharmacy Faculty/Staff Publications

Objectives: The ATS/IDSA Ventilator-Associated Pneumonia (VAP) guidelines suggest that clinical improvement of VAP should be apparent within 3–6 days. This study evaluated resolution of clinical signs of VAP in trauma patients after diagnosis.

Methods: Critically injured adults admitted to the trauma intensive care unit (ICU) from June 1, 2006, to December 31, 2007, and subsequently given a diagnosis of VAP were retrospectively assessed. Clinical signs, including derangements of maximum temperature (Tmax), white blood cell (WBC) count, and PaO2/FiO2, were evaluated on days 1–16 after VAP diagnosis. Data are presented as mean ± SD unless otherwise stated. Clinical ...


Do Atypical Antipsychotics Differ In Determining Long-Term Outcome Of First Episode Schizophrenia? A Naturalistic Outcome Study In India, Amresh Srivastava, Nilesh Shah, Megan Johnston, Larry Stitt, Meghana Thakar, Gurusamy Chinnasamy, Anukant Mital 2010 University of Western Ontario

Do Atypical Antipsychotics Differ In Determining Long-Term Outcome Of First Episode Schizophrenia? A Naturalistic Outcome Study In India, Amresh Srivastava, Nilesh Shah, Megan Johnston, Larry Stitt, Meghana Thakar, Gurusamy Chinnasamy, Anukant Mital

Amresh Srivastava

Antipsychotic medications form the mainstream of treatment in schizophrenia. These drugs have several short term as well long term advantage. It is not known if atypical antipsychotics have the long-term effect in improving outcome and meeting expectations (1,2,3). The present study examined usage and association of antipsychotics drugs with clinical outcome a long-term naturalistic study.


Use Of Parthenolide Derivatives As Antileukemic And Cytotoxic Agents, Peter A. Crooks, Craig T. Jordan, Xiaochen Wei 2010 University of Kentucky

Use Of Parthenolide Derivatives As Antileukemic And Cytotoxic Agents, Peter A. Crooks, Craig T. Jordan, Xiaochen Wei

Pharmaceutical Sciences Faculty Patents

To view this abstract, please download this patent.


Pharmaceutical Philanthropic Shell Games, Lisa Cosgrove, Harold J. Bursztajn 2010 University of Massachusetts Boston

Pharmaceutical Philanthropic Shell Games, Lisa Cosgrove, Harold J. Bursztajn

Counseling and School Psychology Faculty Publication Series

In response to increasing public distrust and congressional concerns regarding pharmaceutical company influence on medical research and education, professional organizations have taken steps to phase out or regulate industry-sponsored educational support. A related problem is industry funding of philanthropic organizations, such as patient advocacy groups. Thus, when the office of Sen Charles Grassley (R-Iowa) recently reported that the National Alliance for the Mentally Ill received substantial pharmaceutical funding, there was concern among the membership’s psychiatric patients and their families.


Countervailing Power In Wholesale Pharmaceuticals, Sara F. Ellison, Christopher M. Snyder 2010 Massachusetts Institute of Technology

Countervailing Power In Wholesale Pharmaceuticals, Sara F. Ellison, Christopher M. Snyder

Open Dartmouth: Faculty Open Access Scholarship

Using data on wholesale prices for antibiotics sold to U.S. drugstores, we test the growing theoretical literature on ‘countervailing power’ (a term for the ability of large buyers to extract discounts from suppliers). Large drugstores receive a modest discount for antibiotics produced by competing suppliers but no discount for antibiotics produced by monopolists. These findings support theories suggesting that supplier competition is a prerequisite for countervailing power. As further evidence for the importance of supplier competition, we find that hospitals receive substantial discounts relative to drugstores, attributed to hospitals' greater ability to induce supplier competition through restrictive formularies.


Development And Validation Of A Rapid Method For The Detection Of Latrunculol A In Plasma., Jiajiu Shaw, Frederick A. Valeriote, Joseph Media, Tyler A. Johnson, Taro Amagata, Karen Tenney, Phillip Crews 2010 Henry Ford Health System, Detroit, Michigan, USA

Development And Validation Of A Rapid Method For The Detection Of Latrunculol A In Plasma., Jiajiu Shaw, Frederick A. Valeriote, Joseph Media, Tyler A. Johnson, Taro Amagata, Karen Tenney, Phillip Crews

Natural Sciences and Mathematics | Faculty Scholarship

Latrunculol A is a recently discovered 6,7-dihydroxy analog of the potent actin inhibitor latrunculin A. Latrunculol A has exhibited greater cytotoxicity than latrunculin A against both murine and human colon tumor cell lines in vitro. Currently, there are no reports regarding the bioavailability of latrunculol A in vivo. This study was undertaken as a prelude to pharmacokinetic assessments and it is the first work where bioavailability of latrunculol A was studied. In the present work, a simple plasma preparation and a rapid HPLC method have been developed. Mouse plasma containing latrunculol A was first treated by acetonitrile and then ...


Targeting Prostate Cancer Cells In Vivo Using A Rapidly Internalizing Novel Human Single-Chain Antibody Fragment., Arun K. Iyer 2010 Northeastern University

Targeting Prostate Cancer Cells In Vivo Using A Rapidly Internalizing Novel Human Single-Chain Antibody Fragment., Arun K. Iyer

Arun Iyer

Human antibodies targeting prostate cancer cell surface epitopes may be useful for imaging and therapy. The objective of this study was to evaluate the tumor targeting of an internalizing human antibody fragment, a small-size platform, to provide high contrast in a mouse model of human prostate carcinoma. METHODS: A prostate tumor-targeting single-chain antibody fragment (scFv), UA20, along with a nonbinding control scFv, N3M2, were labeled with (99m)Tc and evaluated for binding and rapid internalization into human prostate tumor cells in vitro and tumor homing in vivo using xenograft models. For the in vitro studies, the labeled UA20 scFv was ...


Evaluation Of Enteral Feeding Success In Head Injured Patients Placed In Pentobarbital Induced Comas, Jane M. Gervasio, Jonathan Egel, Joshua McGehee, Gabriel Drew Stillabower, Nicole Ponton, Lawrence Bortenschlager, Timothy Pohlman 2010 Butler University

Evaluation Of Enteral Feeding Success In Head Injured Patients Placed In Pentobarbital Induced Comas, Jane M. Gervasio, Jonathan Egel, Joshua Mcgehee, Gabriel Drew Stillabower, Nicole Ponton, Lawrence Bortenschlager, Timothy Pohlman

Scholarship and Professional Work – COPHS

Abstract of Distinction from Clinical Nutrition Week, Las Vegas, NV, February 8-10, 2010.


A Comparison Of Efficacy Of Heparin 0.5 Unit/Ml Versus Heparin 1 Unit/Ml In Parenteral Nutrition Administrated In The Neonatal Population, Jane M. Gervasio, Meredith McKinney, Iftekar Kalsekar, Elaina Szeszycki 2010 Butler University

A Comparison Of Efficacy Of Heparin 0.5 Unit/Ml Versus Heparin 1 Unit/Ml In Parenteral Nutrition Administrated In The Neonatal Population, Jane M. Gervasio, Meredith Mckinney, Iftekar Kalsekar, Elaina Szeszycki

Scholarship and Professional Work – COPHS

Abstract from Clinical Nutrition Week, Las Vegas, NV, February 8-10, 2010.


Stability Of Extemporaneously Prepared Rufinamide Oral Suspensions, David Hutchinson, Yayin Liou, Robert Best, Fang Zhao 2010 St. John Fisher College

Stability Of Extemporaneously Prepared Rufinamide Oral Suspensions, David Hutchinson, Yayin Liou, Robert Best, Fang Zhao

Pharmacy Faculty/Staff Publications

Background:

Rufinamide is an oral antiepileptic drug indicated for adjunctive therapy in treating generalized seizures associated with Lennox-Gastaut syndrome. Currently, rufinanide is available as 200-mg and 400-mg tablets. A liquid dosage form does not exist at the present time. Lack of a suspension formulation may present an administration problem for many children and adults who are unable to swallow tablets. The availability of a liquid dosage form will provide an easy and accurate way to measure and administer the medication.

Objective:

To determine the stability of both sugar-containing and sugar-free rufinamide suspensions over a 90-day period.

Methods:

A suspension of ...


Antidepressant Stimulation Of Cdp-Diacylglycerol Synthesis Does Not Require Monoamine Reuptake Inhibition, Marwa A. Aboukhatwa, Ashiwel S. Undieh 2010 2Department of Pharmaceutical Sciences, University of Maryland

Antidepressant Stimulation Of Cdp-Diacylglycerol Synthesis Does Not Require Monoamine Reuptake Inhibition, Marwa A. Aboukhatwa, Ashiwel S. Undieh

College of Pharmacy Faculty Papers

Background: Recent studies demonstrate that diverse antidepressant agents increase the cellular production of the nucleolipid CDP-diacylglycerol and its synthetic derivative, phosphatidylinositol, in depression-relevant brain regions. Pharmacological blockade of downstream phosphatidylinositide signaling disrupted the behavioral antidepressant effects in rats. However, the nucleolipid responses were resistant to inhibition by serotonin receptor antagonists, even though antidepressant-facilitated inositol phosphate accumulation was blocked. Could the neurochemical effects be additional to the known effects of the drugs on monoamine transmitter transporters? To examine this question, we tested selected agents in serotonin-depleted brain tissues, in PC12 cells devoid of serotonin transporters, and on the enzymatic activity of ...


Methods To Impair Hematologic Cancer Progenitor Cells And Compounds Related Thereto, Craig Jordan 2010 University of Kentucky

Methods To Impair Hematologic Cancer Progenitor Cells And Compounds Related Thereto, Craig Jordan

Pharmaceutical Sciences Faculty Patents

Primitive or progenitor hematologic cancer cells have been implicated in the early stages and development of leukemia and malignant lymphoproliferative disorders, including acute myelogenous leukemia (AML), chronic myelogenous leukemia (CML) and chronic lymphoid leukemia (CLL). Interleukin-3 receptor alpha chain (IL-3Rα or CD123) is strongly expressed on progenitor hematologic cancer cells, but is virtually undetectable on normal bone marrow cells. The present invention provides methods of impairing progenitor hematologic cancer (e.g., leukemia and lymphomic) cells by selectively targeting cells expressing CD123. These methods are useful in the detection and treatment of leukemias and malignant lymphoproliferative disorders. Also provided are compounds ...


Digital Commons powered by bepress